Results

4 stories for“semaglutide heart disease”

Ozempic and Wegovy: What the Trials Actually Showed

Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.

Mar 13, 2024

Health

GLP-1 Drugs Are Becoming More Than Weight Loss Medicine

Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.

Jan 8, 2025

Health

Retatrutide's Third Receptor Is the Hormone That Raises Blood Sugar. Adding It On Purpose Is the Whole Idea

Semaglutide hits one receptor and tirzepatide hits two. The third one retatrutide adds is glucagon, which does the opposite of what a diabetes drug is supposed to do. It is also where the liver results and the safety questions both come from.

Aug 20, 2026

Health

Retatrutide's Phase 3 Run Is Nearly Complete. The Numbers Are the Largest Yet

TRIUMPH-2 and TRIUMPH-3 read out in July, following TRIUMPH-1 in May. Across the programme the triple agonist has produced weight loss in a range no approved obesity drug has reached, with a filing due in early 2027.

Aug 11, 2026